Nomograms provide improved accuracy for predicting survival after radical cystectomy

Area of Science:

• Urology
• Oncology
• Biostatistics

Background:

• Radical cystectomy is a primary treatment for bladder cancer.
• Accurate survival prediction is crucial for patient management and counseling.
• Current staging systems may not fully capture individual prognostic factors.

Purpose of the Study:

• To develop and validate multivariate nomograms for predicting all-cause and bladder cancer-specific survival after radical cystectomy.
• To compare the predictive accuracy of these nomograms against the American Joint Committee on Cancer (AJCC) staging system.

Main Methods:

• Cox proportional hazards regression analysis of 731 patients undergoing radical cystectomy for bladder transitional cell carcinoma.
• Inclusion of variables such as age, gender, pathologic stage (pT), grade, carcinoma in situ, lymphovascular invasion (LVI), lymph node status (pN), neoadjuvant chemotherapy (NACH), adjuvant chemotherapy (ACH), and adjuvant external beam radiotherapy (AXRT).
• Internal validation using 200 bootstrap resamples to mitigate overfit bias.

Main Results:

• Over a mean follow-up of 36.4 months, 39.7% of patients died, with 67.6% of deaths attributed to bladder cancer.
• Developed nomograms demonstrated superior predictive accuracy for both all-cause survival (0.732 vs. 0.615) and cancer-specific survival (0.791 vs. 0.663) compared to AJCC staging (P=0.001 for both).
• Nomogram for all-cause survival included age, pT, pN, LVI, NACH, ACH, and AXRT; cancer-specific survival nomogram included pT, pN, LVI, NACH, and AXRT.

Conclusions:

• Multivariate nomograms offer a more accurate and personalized prediction of survival post-cystectomy.
• These nomograms enhance patient counseling and inform treatment selection decisions.
• Nomograms represent an advancement over conventional prediction models for bladder cancer outcomes.